Emergent BioSolutions Inc. (EBS), a public health company, on Monday announced that the Board has authorized the repurchase of up to $50 million of stock on or before March 27, 2026.
As of December 31, 2024, the company had around 54.3 million outstanding common shares.
In the pre-market trading, Emergent is 3.65% higher at $4.83 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.